Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Overall Survival Analysis of Patients With R/R LBCL Receiving Axicabtagene Ciloleucel vs Standard of Care Therapy: ZUMA-7 Study
10/23/2023
Grace Taylor, MS, MA
Jason Westin, MD, and colleagues examined the overall survival of patients with R/R LBCL who received axicabtagene ciloleucel vs standard of care for second-line therapy as part of the ZUMA-7 clinical trial.
Jason Westin, MD, and colleagues examined the overall survival of patients with R/R LBCL who received axicabtagene ciloleucel vs standard of care for second-line therapy as part of the ZUMA-7 clinical trial.
Jason Westin, MD, and colleagues...
10/23/2023
Pharmacy Learning Network

Advertisement

News
Federal Initiative to Address Growing Problem of Overdoses Among Expectant Mothers
10/23/2023
Jazmin Orozco Rodriguez and Katheryn ...
A federal initiative seeking to combat overdoses is distributing millions of dollars to states to help fund and expand programs. Six states will receive grant funding from the Substance Abuse and Mental Health Services Administration to...
A federal initiative seeking to combat overdoses is distributing millions of dollars to states to help fund and expand programs. Six states will receive grant funding from the Substance Abuse and Mental Health Services Administration to...
A federal initiative seeking to...
10/23/2023
Pharmacy Learning Network
News
International Reference Pricing for Prescription Drugs Presents Administrative Complications
10/23/2023
Jolynn Tumolo
The commentary explains that cross-referencing prices between countries is a problem because price changes in one country ripple out to others and compound the effects of the price decrease.
The commentary explains that cross-referencing prices between countries is a problem because price changes in one country ripple out to others and compound the effects of the price decrease.
The commentary explains that...
10/23/2023
Pharmacy Learning Network
News
Society Not Likely to Benefit From Government Say in Drug Pricing
10/21/2023
Jolyn Tumolo
Little evidence suggests that US government regulation of prescription drug prices would offer a net benefit to society, according to a critical review and of the literature published in Research in Social and Administrative Pharmacy.
Little evidence suggests that US government regulation of prescription drug prices would offer a net benefit to society, according to a critical review and of the literature published in Research in Social and Administrative Pharmacy.
Little evidence suggests that US...
10/21/2023
Pharmacy Learning Network

Advertisement

News
Poll: Half of Adults in their 60s and 70s Do Not Know About RSV Vaccines
10/20/2023

Danielle Sposato  

Danielle Sposato  
A recent University of Michigan poll found that nearly half of older adults were unaware of the new respiratory syncytial virus (RSV) vaccines.
A recent University of Michigan poll found that nearly half of older adults were unaware of the new respiratory syncytial virus (RSV) vaccines.
A recent University of Michigan...
10/20/2023
Pharmacy Learning Network
News
Examining State Drug Pricing Transparency Laws’ Impact on Supply Chain Transparency
10/18/2023
Hannah Musick
Despite the implementation of state drug pricing transparency laws, researchers found most of these laws are insufficient in revealing the true transaction prices and profits across the entire drug supply chain in the US.
Despite the implementation of state drug pricing transparency laws, researchers found most of these laws are insufficient in revealing the true transaction prices and profits across the entire drug supply chain in the US.
Despite the implementation of...
10/18/2023
Pharmacy Learning Network
News
Liquid Plasma Recalled
10/18/2023
Jolynn Tumolo
The FDA has issued a Class II recall for liquid plasma distributed across 17 states.
The FDA has issued a Class II recall for liquid plasma distributed across 17 states.
The FDA has issued a Class II...
10/18/2023
Pharmacy Learning Network

Advertisement

News
Frozen Plasma Recalled
10/18/2023
Jolynn Tumolo
The American National Red Cross recalled one unit of PF 24 plasma, citing improper performance of arm prep. The recall was included in the October 18, 2023, US Food and Drug Administration (FDA) Enforcement Report.
The American National Red Cross recalled one unit of PF 24 plasma, citing improper performance of arm prep. The recall was included in the October 18, 2023, US Food and Drug Administration (FDA) Enforcement Report.
The American National Red Cross...
10/18/2023
Pharmacy Learning Network
News
Antifungal Tablets Under Class I Recall
10/18/2023
Jolynn Tumolo
The FDA has issues a Class I recall for an antifungal prescription drug indicated for treating vulvovaginal candidiasis and reducing the incidence of recurrent vulvovaginal candidiasis.
The FDA has issues a Class I recall for an antifungal prescription drug indicated for treating vulvovaginal candidiasis and reducing the incidence of recurrent vulvovaginal candidiasis.
The FDA has issues a Class I...
10/18/2023
Pharmacy Learning Network
News
NCCN Updates Clinical Practice Guidelines for B-Cell Lymphomas
10/17/2023
Grace Taylor, MS, MA
NCCN recently published updated recommendations for the treatment of diffuse large B-cell lymphoma (DLBCL) and histologic transformation of indolent lymphomas to DLBCL.
NCCN recently published updated recommendations for the treatment of diffuse large B-cell lymphoma (DLBCL) and histologic transformation of indolent lymphomas to DLBCL.
NCCN recently published updated...
10/17/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use